4596-23-0 (枸橼酸奥芬那君,Orphenadrine citrate)

枸橼酸奥芬那君;N,N-二甲基-2-[(2-甲基苯基)苯甲氧基]乙胺 2-羟基-1,2,3-丙三羧酸盐;

Orphenadrine citrate;Norflex;N,N-Dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine 2-hydroxypropane-1,2,3-tricarboxylic acid salt;ORPHENADRINE CITRATE, USP;o-Methyldiphenhydramine citrate salt;ORPHENGESIC FORTE COMPONENT ORPHENADRINE CITRATE;(+/-)-N,N-DIMETHYL-2-((O-METHYL-alpha-PHENYLBENZYL)OXY)ETHYLAMINE CITRATE (1:1);ORPHENADRINE CITRATE [EP MONOGRAPH];(+-)-N,N-Dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate (1:1);NCGC00254980-01;NSC757238;Flexor;N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate;Orphenadrinecitrate;ORPHENADRINE CITRATE COMPONENT OF ORPHENGESIC;Tox21_111323_1;D00774;citric acid; N,N-dimethyl-2-[o-tolyl(phenyl)methoxy]ethanamine;(+-)-N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate;ORPHENADRINE CITRATE [WHO-DD];HMS3259M21;Orphenadrine citrate [USP];S2054;ORPHENGESIC COMPONENT ORPHENADRINE CITRATE;MLS000069549;HMS502K15;HMS3651A10;ORPHENADRINE CITRATE COMPONENT OF INVAGESIC;FT-0655842;Tega-Flex;X-Otag;4596-23-0;Banflex;Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, 2-hydroxy-1,2,3-propanetricarboxylate(1:1);Ethylamine, N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)-, citrate (1:1);EINECS 225-137-5;Tox21_301079;ORPHENADRINE CITRATE [EP IMPURITY];NCGC00015771-13;ORPHENADRINE CITRATE [MI];Citrate, Orphenadrine;ORPHENADRINE CITRATE [ORANGE BOOK];Z234896463;Ethanamine, N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);Q27107584;X0A40N8I4S;C75247;N,N-dimethyl-2-(phenyl(o-tolyl)methoxy)ethan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate;SPECTRUM1500447;DTXSID8044678;CHEMBL1200395;CHEBI:7790;ORPHENADRINE CITRATE (USP MONOGRAPH);N,N-dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine 2-hydroxypropane-1,2,3-tricarboxylate;SR-01000002975-5;ORPHENADRINE CITRATE COMPONENT OF ORPHENGESIC FORTE;N,N-dimethyl-2-((2-methylphenyl)(phenyl)methoxy)ethanamine 2-hydroxypropane-1,2,3-tricarboxylate;N,N-Dimethyl-2-(phenyl(o-tolyl)methoxy)ethanamine 2-hydroxypropane-1,2,3-tricarboxylate;NCGC00094745-03;Pharmakon1600-01500447;C24H31NO8;INVAGESIC COMPONENT ORPHENADRINE CITRATE;FT-0673305;(+/-)-N,N-DIMETHYL-2-((O-METHYL-.ALPHA.-PHENYLBENZYL)OXY)ETHYLAMINE CITRATE (1:1);Norflex (TN);CAS-4682-36-4;A826945;Tox21_111323;ORPHENADINE CITRATE;NS00082653;NCGC00094745-02;HMS3370M12;Euflex;Orphenadrine citrate salt;Plenactol;INVAGESIC FORTE COMPONENT ORPHENADRINE CITRATE;SMR000058817;Tox21_113543;HMS2231J06;EN300-53019;Flexon;UNII-X0A40N8I4S;HY-B0369A;HMS3884M22;SCHEMBL119470;ORPHENADRINE CITRATE COMPONENT OF NORGESIC;AS-74807;ORPHENADRINE CITRATE (MART.);HMS1920D10;Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1);Orphenadrine citrate (Norflex);NSC 757238;NORGESIC COMPONENT ORPHENADRINE CITRATE;ORPHENADRINE CITRATE (EP IMPURITY);Norflex (pharmaceutical);Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, (+-)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1);NSC-757238;DTXCID6024678;N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid;AKOS008132385;N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine; 2-hydroxypropane-1,2,3-tricarboxylic acid;ETHANAMINE, N,N-DIMETHYL-2-((2-METHYLPHENYL)PHENYLMETHOXY)-, (+/-)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1);Orphenadrine dihydrogen citrate;Orphenadrine citrate (USP);ORPHENADRINE CITRATE [VANDF];ORPHENADRINE CITRATE [USP MONOGRAPH];ORPHENADRINE CITRATE COMPONENT OF INVAGESIC FORTE;Orphenadrine citrate; (RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate;Orphenadrine (Citrate);HMS2091L10;Flexoject;ORPHENADRINE CITRATE [MART.];2-hydroxypropane-1,2,3-tricarboxylic acid; dimethyl({2-[(2-methylphenyl)(phenyl)methoxy]ethyl})amine;NCGC00094745-01;N,N-Dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate (1:1);BETA-DIMETHYLAMINOETHYL 2-METHYLBENZHYDRYL ETHER CITRATE SALT;4682-36-4;ORPHENADRINE CITRATE (EP MONOGRAPH);SW102176-4;CCG-40242;Orphenadrine CitrateER;NC00525;

MMMNTDFSPSQXJP-UHFFFAOYSA-N

1S/C18H23NO.C6H8O7/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-12,18H,13-14H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

O(CCN(C)C)C(C1C=CC=CC=1)C1C=CC=CC=1C.OC(C(=O)O)(CC(=O)O)CC(=O)O

2922199090